FDA Inspection
BioLyte Laboratories, LLCBioLyte Laboratories, LLC – FDA Inspection, Dec 15, 2017
Record Details
This FDA Inspection record concerns BioLyte Laboratories, LLC, with an inspection on December 15, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c4f9e3a9-094d-411b-a252-9955ae71867e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1035012
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.84(d)(2)Component identification test
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BioLyte Laboratories, LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 12, 2025 | Not classified | Detroit District Office | |
| April 27, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 6, 2023 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| December 18, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BioLyte Laboratories, LLC
- FDA Inspection 1287796 - 2025-09-12
- FDA Inspection 1205037 - 2023-04-27
- FDA Inspection 1203096 - 2023-04-06
- FDA Inspection 1113105 - 2019-12-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.